BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9169817)

  • 1. Localized primary malignant lymphoma of bone.
    Dubey P; Ha CS; Besa PC; Fuller L; Cabanillas F; Murray J; Hess MA; Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1087-93. PubMed ID: 9169817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localized primary non-Hodgkin lymphoma of the breast.
    Ha CS; Dubey P; Goyal LK; Hess M; Cabanillas F; Cox JD
    Am J Clin Oncol; 1998 Aug; 21(4):376-80. PubMed ID: 9708637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary non-Hodgkin's lymphoma of the bone: treatment and analysis of prognostic factors for Stage I and Stage II.
    Barbieri E; Cammelli S; Mauro F; Perini F; Cazzola A; Neri S; Bunkheila F; Ferrari S; Brandoli V; Zinzani P; Mercuri M; Bacci G
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):760-4. PubMed ID: 15183479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic management with adriamycin-containing chemotherapy and radiotherapy of monostotic and polyostotic primary non-Hodgkin's lymphoma of bone in adults.
    Ferreri AJ; Reni M; Ceresoli GL; Villa E
    Cancer Invest; 1998; 16(8):554-61. PubMed ID: 9844615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
    Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma.
    Tao R; Allen PK; Rodriguez A; Shihadeh F; Pinnix CC; Arzu I; Reed VK; Oki Y; Westin JR; Fayad LE; Medeiros LJ; Dabaja B
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):122-9. PubMed ID: 25754633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy.
    Logsdon MD; Ha CS; Kavadi VS; Cabanillas F; Hess MA; Cox JD
    Cancer; 1997 Aug; 80(3):477-88. PubMed ID: 9241082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum.
    Nguyen LN; Ha CS; Hess M; Romaguera JE; Manning JT; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1281-5. PubMed ID: 10889382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of stage IE primary lymphoma of bone.
    Fairbanks RK; Bonner JA; Inwards CY; Strickler JG; Habermann TM; Unni KK; Su J
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):363-72. PubMed ID: 8276651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis of primary non-Hodgkin's lymphoma of the breast].
    Guo HY; Zhao XM; Cao JN; Hu XC; Yin JL; Hong XN; Li J
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):200-2. PubMed ID: 18756936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
    Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.
    Schlembach PJ; Wilder RB; Tucker SL; Ha CS; Rodriguez MA; Hess MA; Cabanillas FF; Cox JD
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1107-10. PubMed ID: 11072169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary lymphoma of bone: a prospective study of 28 cases.
    Brousse C; Baumelou E; Morel P
    Joint Bone Spine; 2000; 67(5):446-51. PubMed ID: 11143912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil].
    Qin Y; Shi YK; He XH; Yang JL; Yang S; Yu YX; Li B; Wang QL; Zhou LQ; Sun Y
    Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.
    Wilder RB; Tucker SL; Ha CS; Rodriguez MA; Hess MA; Cabanillas FF; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):17-22. PubMed ID: 11163493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study).
    Bruno Ventre M; Ferreri AJ; Gospodarowicz M; Govi S; Messina C; Porter D; Radford J; Heo DS; Park Y; Martinelli G; Taylor E; Lucraft H; Hong A; Scarfò L; Zucca E; Christie D;
    Oncologist; 2014 Mar; 19(3):291-8. PubMed ID: 24567283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
    Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiotherapy of primary extranodal non-Hodgkin's lymphoma of the head and neck region. Results of a prospective multicenter study. Study Group NHL: early studies].
    Hoederath A; Sack H; Stuschke M; Lampka E
    Strahlenther Onkol; 1996 Jul; 172(7):356-66; discussion 367-8. PubMed ID: 8693402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy.
    Sarris AH; Braunschweig I; Medeiros LJ; Duvic M; Ha CS; Rodriguez MA; Hagemeister FB; McLaughlin P; Romaguera J; Cox J; Cabanillas F
    J Clin Oncol; 2001 Jan; 19(2):398-405. PubMed ID: 11208831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.